Educational Reports
Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes
2023 Volume 72 Issue 2 Pages 177-178
Details
2023 Volume 72 Issue 2 Pages 177-178
Objectives: The cost-effectiveness of lifestyle intervention for preventing kidney disease in patients with type 2 diabetes was not fully elucidated.
Methods: We developed the Markov model with a Japanese healthcare payer’s perspective to examine the cost-effectiveness of lifestyle interventions for preventing the development of kidney disease among patients with diabetes. Model parameters, including the lifestyle intervention effect, were derived from the results of the published literatures. The incremental cost-effectiveness ratios (ICER) were calculated from the difference in cost and quality-adjusted life years (QALY) between the lifestyle intervention and diabetes support education group.
Results: The ICER for the lifestyle intervention compared with the diabetes support education was JPY 1,510,838 per QALY.
Conclusions: The results of the present study showed that the lifestyle intervention for the prevention of kidney disease in patients with diabetes would be cost-effective from a Japanese healthcare payer’s perspective compared to the diabetes support education.
